asianprimenews
GeneralPublic Interest

Allchem Lifescience Limited*, an Indian manufacturer of active pharmaceutical ingredients (API) intermediates and speciality chemicals, has received SEBI approval for their IPO

The IPO comprises of a fresh issue of equity shares of face value of ₹10 each aggregating up to ₹ 190 Crores and an offer for sale of up to 7,155,000 equity shares of face value of ₹ 10 each. The offer for sale comprises of up to 3,577,500 equity shares of face value of ₹ 10 each by Kantilal Ramanlal Patel and up to 3,577,500 equity shares of face value of ₹ 10 each by Manisha Bipin Patel (Promoter Selling Shareholder).

Emkay Global Financial Services Limited is the sole Book Running Lead Manager to the issue.

DRHP Link: https://www.bseindia.com/corporates/download/384931/IPO%20Prior/ALLCHEMLIFESCIENCELIMITEDDRHP_20250313212701.pdf

SEBI processing status link: https://www.sebi.gov.in/filings/processing-status/aug-2025/processing-status-issues_59558.html

Share

Related posts

On-screen lovebirds Nishant Malkaani and Nyrraa M Banerji are back with Pocket FM’s ‘Insta Empire’

asianprimenews

Director Abhishek Kapoor Pens a Heartfelt Note as Azaad Gets Its Due Recognition, Shares Insights From Shoot, Reactions on OTT Release, and More

asianprimenews

Kia becomes the fastest carmaker to achieve 1 Million Domestic Sales

asianprimenews